Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2176 | 2257 | 39.8 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1439 | 7339 | BNCT//BORON NEUTRON CAPTURE THERAPY//TIRAPAZAMINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARBOGEN | Author keyword | 97 | 64% | 4% | 96 |
2 | TUMOR HYPOXIA | Author keyword | 63 | 42% | 5% | 114 |
3 | TUMOR OXYGENATION | Author keyword | 54 | 52% | 3% | 74 |
4 | PIMONIDAZOLE | Author keyword | 45 | 57% | 2% | 53 |
5 | FMISO | Author keyword | 32 | 85% | 1% | 17 |
6 | CU ATSM | Author keyword | 25 | 70% | 1% | 21 |
7 | HYPOXIA MARKER | Author keyword | 25 | 77% | 1% | 17 |
8 | F 18 FAZA | Author keyword | 24 | 82% | 1% | 14 |
9 | FAZA | Author keyword | 24 | 91% | 0% | 10 |
10 | 2 NITROIMIDAZOLE | Author keyword | 22 | 56% | 1% | 27 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARBOGEN | 97 | 64% | 4% | 96 | Search CARBOGEN | Search CARBOGEN |
2 | TUMOR HYPOXIA | 63 | 42% | 5% | 114 | Search TUMOR+HYPOXIA | Search TUMOR+HYPOXIA |
3 | TUMOR OXYGENATION | 54 | 52% | 3% | 74 | Search TUMOR+OXYGENATION | Search TUMOR+OXYGENATION |
4 | PIMONIDAZOLE | 45 | 57% | 2% | 53 | Search PIMONIDAZOLE | Search PIMONIDAZOLE |
5 | FMISO | 32 | 85% | 1% | 17 | Search FMISO | Search FMISO |
6 | CU ATSM | 25 | 70% | 1% | 21 | Search CU+ATSM | Search CU+ATSM |
7 | HYPOXIA MARKER | 25 | 77% | 1% | 17 | Search HYPOXIA+MARKER | Search HYPOXIA+MARKER |
8 | F 18 FAZA | 24 | 82% | 1% | 14 | Search F+18+FAZA | Search F+18+FAZA |
9 | FAZA | 24 | 91% | 0% | 10 | Search FAZA | Search FAZA |
10 | 2 NITROIMIDAZOLE | 22 | 56% | 1% | 27 | Search 2+NITROIMIDAZOLE | Search 2+NITROIMIDAZOLE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | F 18 FLUOROMISONIDAZOLE | 253 | 74% | 8% | 186 |
2 | TUMOR HYPOXIA | 104 | 29% | 14% | 308 |
3 | FLUOROMISONIDAZOLE | 69 | 75% | 2% | 49 |
4 | IMAGING HYPOXIA | 65 | 78% | 2% | 43 |
5 | CARBOGEN | 65 | 51% | 4% | 92 |
6 | RADIOLABELED FLUOROMISONIDAZOLE | 62 | 90% | 1% | 27 |
7 | IODOAZOMYCIN ARABINOSIDE | 62 | 85% | 1% | 33 |
8 | PREDICTS RADIATION RESPONSE | 58 | 50% | 4% | 83 |
9 | O2 TENSION MEASUREMENTS | 54 | 52% | 3% | 74 |
10 | PIMONIDAZOLE BINDING | 54 | 72% | 2% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects | 2001 | 1078 | 130 | 58% |
Imaging hypoxia to improve radiotherapy outcome | 2012 | 59 | 113 | 77% |
Hypoxia in cancer: significance and impact on clinical outcome | 2007 | 587 | 136 | 40% |
Molecular imaging of hypoxia with radiolabelled agents | 2009 | 85 | 130 | 91% |
Imaging tumour hypoxia with positron emission tomography | 2015 | 1 | 87 | 89% |
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response | 2008 | 317 | 139 | 39% |
Implementation of hypoxia imaging into treatment planning and delivery | 2010 | 42 | 58 | 90% |
Molecular imaging of hypoxia in non-small-cell lung cancer | 2015 | 1 | 89 | 75% |
Molecular imaging of hypoxia | 2008 | 162 | 192 | 63% |
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis | 2011 | 100 | 87 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT CLIN ONCOL | 10 | 14% | 2.8% | 64 |
2 | MOL IMAGING EXPT RADIOTHER Y | 9 | 36% | 0.9% | 20 |
3 | MED CHEM RADIOPHARM | 9 | 33% | 1.0% | 22 |
4 | RADIOBIOL RADIOPROTECT UNIT | 8 | 75% | 0.3% | 6 |
5 | GRP RADIAT BIOL TUMOR PHYSIOL | 8 | 34% | 0.8% | 19 |
6 | RADIAT ONCOL TOXICOL | 6 | 100% | 0.2% | 4 |
7 | MED BIOL PROD PROGRAM | 5 | 60% | 0.3% | 6 |
8 | GRAY CANC TRUST | 5 | 27% | 0.8% | 17 |
9 | CRCBIOMED MAGNET ONANCE GRP | 4 | 67% | 0.2% | 4 |
10 | RADIOACT ISOTOPES GENERATOR | 4 | 56% | 0.2% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000224176 | QUIESCENT CELL//BORON TRACEDRUG//MILD TEMPERATURE HYPERTHERMIA |
2 | 0.0000203853 | TIRAPAZAMINE//HYPOXIC CELL RADIOSENSITIZER//KU 2285 |
3 | 0.0000133662 | TCD50//REPOPULATION//R1H RHABDOMYOSARCOMA |
4 | 0.0000118128 | INTERSTITIAL FLUID PRESSURE//EDWIN L STEELE//CANCER DETECTION AND TREATMENT |
5 | 0.0000114507 | ORP150//OXYGEN REGULATED PROTEIN 150//REPLICON INITIATION |
6 | 0.0000113896 | PHLIP//TUMOR ACIDITY//TUMOR PH |
7 | 0.0000086876 | GLUT 1//GLUCOSE TRANSPORTER 1//GLUT 1 EXPRESSION |
8 | 0.0000084405 | DCE MRI//PHARMACEUT MOL IMAGING//DYNAMIC CONTRAST ENHANCED MRI |
9 | 0.0000083733 | F 19 MRI//FLUORINE STUDIES//19F MRI |
10 | 0.0000073398 | FLUOSOL//PERFLUOROCHEMICAL EMULSION//BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS |